52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

Data provided by Thomson Reuters

Recent Dividends & Distributions

More
US RECORD DATE US PAYABLE DATE NET DR AMOUNT
Mar 21, 2025 Apr 29, 2025 0.6083
Sep 18, 2024 Oct 25, 2024 0.6537
Mar 22, 2024 Apr 30, 2024 0.5823
Sep 18, 2023 Oct 26, 2023 0.5102

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
RhumbLine Advisers LP 2,228
Langar Investment Management LLC 688
ShariaPortfolio, Inc. 345
TOP MUTUAL FUND HOLDERS POSITION
Langar Global HealthTech ETF 688
SP Funds S&P World (ex-US) ETF 345
Avantis US Quality ETF 73

Data provided by FactSet Research Systems Inc.

Important Notice to Investors of Unsponsored DRs and GDNs:

From time to time, BNY may pay a rebate to brokers that deposit shares with BNY for the issuance of unsponsored depositary receipts (DRs) or global depositary notes. BNY assumes no obligation or responsibility, and expressly disclaims any liability arising out of, or relating to, such rebates, including without limitation whether the rebate or any portion of it is passed on to the beneficial holders by the brokers.
Unsponsored DRs may be issued by multiple depositary banks servicing a particular DR program. Consequently, as a result of Depository Trust & Clearing Corporation (“DTCC”) practice, the actual cash distribution fees charged may differ from the BNY fees detailed in the fee schedule as fees will be charged in accordance with the fee schedule of the depositary bank that is considered to be the “First Filer”. The fees to be charged for any particular unsponsored cash distribution will be disclosed on the event announcement published by the “First Filer”. BNY takes no responsibility for the level of fees charged by any other depositary bank. The “First Filer” is the depositary bank that filed the first Form F-6 for a program with the U.S. Securities and Exchange Commission (“SEC”). In the event the actual “First Filer” does not have DRs outstanding for a program, the next depositary bank who filed a
Form F-6 with the SEC and has DRs outstanding will be deemed to be the First Filer for these purposes.

DR Details

DR Symbol CHEOY
CUSIP 191459205
DR Venue OTC
DR ISIN US1914592050
Ratio DR:ORD 2:1
First Filer BK
Underlying ISIN AU000000COH5
Underlying SEDOL 6211798
Country Australia
Effective Date Jan 16, 2009
Depositary BK, CIT, DB, JPMC (Unsponsored)
Industry HealthCareEquip.&Ser
Cochlear is engaged in implantable hearing solutions. The Company's products include: cochlear implants, which include Cochlear (TM) Nucleus® Profile (TM) Plus implant and Slim Modiolar electrode; acoustic implants, which include Cochlear (TM) Osia® 2 System; sound processors, which include Cochlear (TM) Nucleus® 7 Sound Processor, Cochlear (TM) Nucleus® Kanso® 2 Sound Processor and Cochlear (TM) Baha® 6 Max Sound Processor; convenience and confidence, which include Nucleus, Baha & Osia Smart Apps and Cochlear (TM) CoPilot; clinical and surgical support, which includes Custom Sound® Pro Fitting Software and Nucleus® SmartNav System; and telehealth solutions, which include Remote Check solution for cochlear implants.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.1000
Cancellation up to $0.1000
Cash Distribution up to $0.1000
Issuance up to $0.1000
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.1000
Rights - Issuance up to $0.1000
Stock Dividend up to $0.1000
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 86.87 464,849 22,136
Mar.25 83.16 398,275 18,965
Feb.25 80.82 348,750 18,355

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE